656 related articles for article (PubMed ID: 19075005)
21. Mechanism of cell cycle entry mediated by the intrinsically disordered protein p27(Kip1).
Ou L; Waddell MB; Kriwacki RW
ACS Chem Biol; 2012 Apr; 7(4):678-82. PubMed ID: 22276948
[TBL] [Abstract][Full Text] [Related]
22. Incomplete folding upon binding mediates Cdk4/cyclin D complex activation by tyrosine phosphorylation of inhibitor p27 protein.
Ou L; Ferreira AM; Otieno S; Xiao L; Bashford D; Kriwacki RW
J Biol Chem; 2011 Aug; 286(34):30142-51. PubMed ID: 21715330
[TBL] [Abstract][Full Text] [Related]
23. B cell antigen receptor-mediated activation of cyclin-dependent retinoblastoma protein kinases and inhibition by co-cross-linking with Fc gamma receptors.
Tanguay D; Pavlovic S; Piatelli MJ; Bartek J; Chiles TC
J Immunol; 1999 Sep; 163(6):3160-8. PubMed ID: 10477583
[TBL] [Abstract][Full Text] [Related]
24. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
Phelps DE; Xiong Y
Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
[TBL] [Abstract][Full Text] [Related]
25. Cyclin-dependent kinase-2 (Cdk2) forms an inactive complex with cyclin D1 since Cdk2 associated with cyclin D1 is not phosphorylated by Cdk7-cyclin-H.
Higashi H; Suzuki-Takahashi I; Saitoh S; Segawa K; Taya Y; Okuyama A; Nishimura S; Kitagawa M
Eur J Biochem; 1996 Apr; 237(2):460-7. PubMed ID: 8647086
[TBL] [Abstract][Full Text] [Related]
26. Monoclonal antibodies to activated CDK4: use to investigate normal and cancerous cell cycle regulation and involvement of phosphorylations of p21 and p27.
Coulonval K; Vercruysse V; Paternot S; Pita JM; Corman R; Raspé E; Roger PP
Cell Cycle; 2022 Jan; 21(1):12-32. PubMed ID: 34913830
[TBL] [Abstract][Full Text] [Related]
27. Activation of cyclin D1-kinase in murine fibroblasts lacking both p21(Cip1) and p27(Kip1).
Sugimoto M; Martin N; Wilks DP; Tamai K; Huot TJ; Pantoja C; Okumura K; Serrano M; Hara E
Oncogene; 2002 Nov; 21(53):8067-74. PubMed ID: 12444543
[TBL] [Abstract][Full Text] [Related]
28. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).
Depoortere F; Pirson I; Bartek J; Dumont JE; Roger PP
Mol Biol Cell; 2000 Mar; 11(3):1061-76. PubMed ID: 10712520
[TBL] [Abstract][Full Text] [Related]
29. Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors.
Parry D; Mahony D; Wills K; Lees E
Mol Cell Biol; 1999 Mar; 19(3):1775-83. PubMed ID: 10022865
[TBL] [Abstract][Full Text] [Related]
30. A dominant-negative cyclin D1 mutant prevents nuclear import of cyclin-dependent kinase 4 (CDK4) and its phosphorylation by CDK-activating kinase.
Diehl JA; Sherr CJ
Mol Cell Biol; 1997 Dec; 17(12):7362-74. PubMed ID: 9372967
[TBL] [Abstract][Full Text] [Related]
31. JNKs function as CDK4-activating kinases by phosphorylating CDK4 and p21.
Colleoni B; Paternot S; Pita JM; Bisteau X; Coulonval K; Davis RJ; Raspé E; Roger PP
Oncogene; 2017 Jul; 36(30):4349-4361. PubMed ID: 28368408
[TBL] [Abstract][Full Text] [Related]
32. Regulation of CDK7-carboxyl-terminal domain kinase activity by the tumor suppressor p16(INK4A) contributes to cell cycle regulation.
Nishiwaki E; Turner SL; Harju S; Miyazaki S; Kashiwagi M; Koh J; Serizawa H
Mol Cell Biol; 2000 Oct; 20(20):7726-34. PubMed ID: 11003668
[TBL] [Abstract][Full Text] [Related]
33. Brk/Protein tyrosine kinase 6 phosphorylates p27KIP1, regulating the activity of cyclin D-cyclin-dependent kinase 4.
Patel P; Asbach B; Shteyn E; Gomez C; Coltoff A; Bhuyan S; Tyner AL; Wagner R; Blain SW
Mol Cell Biol; 2015 May; 35(9):1506-22. PubMed ID: 25733683
[TBL] [Abstract][Full Text] [Related]
34. Regulation of G(1) cyclin-dependent kinases in the liver: role of nuclear localization and p27 sequestration.
Albrecht JH; Rieland BM; Nelsen CJ; Ahonen CL
Am J Physiol; 1999 Dec; 277(6):G1207-16. PubMed ID: 10600818
[TBL] [Abstract][Full Text] [Related]
35. New functional activities for the p21 family of CDK inhibitors.
LaBaer J; Garrett MD; Stevenson LF; Slingerland JM; Sandhu C; Chou HS; Fattaey A; Harlow E
Genes Dev; 1997 Apr; 11(7):847-62. PubMed ID: 9106657
[TBL] [Abstract][Full Text] [Related]
36. The CDK4/CDK6 inhibitor PD0332991 paradoxically stabilizes activated cyclin D3-CDK4/6 complexes.
Paternot S; Colleoni B; Bisteau X; Roger PP
Cell Cycle; 2014; 13(18):2879-88. PubMed ID: 25486476
[TBL] [Abstract][Full Text] [Related]
37. Cyclic AMP inhibits the proliferation of thyroid carcinoma cell lines through regulation of CDK4 phosphorylation.
Rocha AS; Paternot S; Coulonval K; Dumont JE; Soares P; Roger PP
Mol Biol Cell; 2008 Nov; 19(11):4814-25. PubMed ID: 18799615
[TBL] [Abstract][Full Text] [Related]
38. Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1).
Cheng M; Sexl V; Sherr CJ; Roussel MF
Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1091-6. PubMed ID: 9448290
[TBL] [Abstract][Full Text] [Related]
39. Analysis of cyclin D3-cdk4 complexes in fibroblasts expressing and lacking p27(kip1) and p21(cip1).
Bagui TK; Jackson RJ; Agrawal D; Pledger WJ
Mol Cell Biol; 2000 Dec; 20(23):8748-57. PubMed ID: 11073976
[TBL] [Abstract][Full Text] [Related]
40. Involvement of p21 and p27 in the regulation of CDK activity and cell cycle progression in the regenerating liver.
Albrecht JH; Poon RY; Ahonen CL; Rieland BM; Deng C; Crary GS
Oncogene; 1998 Apr; 16(16):2141-50. PubMed ID: 9572495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
